Case Report
Accepted on 22 Nov 2024
Case Report: high-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1514471
Type at least 3 characters
902 articles
Articles
Case Report
Published on 22 Nov 2024
Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1440246
- 196 views
Original Research
Published on 22 Nov 2024
Trajectory of psychological distress and influencing factors in patients with gynecological cancers: a longitudinal study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1380916
- 145 views
Systematic Review
Published on 21 Nov 2024
The correlation between vaginal pathogens and high-risk human papilloma virus infection: a meta-analysis of case-control studies
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1423118
- 147 views
Original Research
Published on 21 Nov 2024
An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1429176
- 147 views
Systematic Review
Published on 21 Nov 2024
Acupuncture combined with Chinese herbs versus Chinese herbs alone to improve the clinical efficacy of uterine fibroids: a systematic review and meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1456809
- 131 views
Original Research
Published on 20 Nov 2024
The value of multi-parameter radiomics combined with imaging features in predicting the therapeutic efficacy of HIFU treatment for uterine fibroids
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1499387
- 177 views
Review
Accepted on 19 Nov 2024
Effectiveness of Continuity of Care in Postoperative Patients with Cervical Cancer: A systematic Evaluation and Meta-analysis of a
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1461296
Case Report
Accepted on 19 Nov 2024
High-intensity focused ultrasound (HIFU) assisted by a rectal Foley catheter for the treatment of recurrent mucinous ovarian cancer: a case report and literature review
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1498631
Original Research
Accepted on 18 Nov 2024
Prognostic Significance of CNNM4 in Ovarian Cancer: A Comprehensive Bioinformatics Analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1483425
Original Research
Accepted on 18 Nov 2024
Comprehensive Diagnostic and Therapeutic Approaches to Uterine Teratoma in Postmenopausal Women: A Case Study and Review
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1458187
Systematic Review
Published on 18 Nov 2024
Efficacy and safety of angiogenesis inhibitors combined with poly ADP ribose polymerase inhibitors in the maintenance treatment of advanced ovarian cancer: a meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1477105
- 210 views
Original Research
Accepted on 15 Nov 2024
Vitronectin promotes proliferation and metastasis of cervical cancer cells via the epithelial-mesenchymal transition
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1466264
Original Research
Published on 15 Nov 2024
Effect of endometriosis on prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1438309
- 173 views
Original Research
Published on 14 Nov 2024
The impact of lymphadenectomy on the survival of patients with stage I ovarian clear cell carcinoma
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1425214
- 208 views
Original Research
Published on 14 Nov 2024
Potential shared gene signatures and molecular mechanisms between recurrent pregnancy loss and ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1445502
- 235 views